Expert Consensus on Dipeptidyl Peptidase-4 Inhibitor-Based Therapies in the Modern Era of Type 2 Diabetes Mellitus Management in India

• Published in: Curēus (Palo Alto, CA) Vol. 16; no. 6; p. e61766
• Main Authors: Kalra, Sanjay, Bhattacharya, Saptarshi, Dhingra, A, Das, Sambit, Kapoor, Nitin, Shaikh, Shehla, Kolapkar, Vivek, Lokesh Kumar, R V, Patel, Kamlesh, Kotwal, Rahul
• Format: Journal Article
• Language: English
• Published: United States Springer Nature B.V 05.06.2024; Cureus
• Subjects: Chemical bonds; Clinical medicine; Diabetes; Drug dosages; Endocrinology/Diabetes/Metabolism; Glucagon; Glucose; Hypoglycemia; Kidney diseases; Medical Education; Oral Medicine; Patient satisfaction; Peptides; White people; India; dpp-4 inhibitors; type 2 diabetes mellitus; combination therapy; glycemic control; vildagliptin; individualized therapy

India has a high prevalence of type 2 diabetes mellitus (T2DM) with unique clinical characteristics compared to other populations. Despite advancements in diabetes therapy, a significant number of patients in India still experience poor glycemic control and complications. Dipeptidyl peptidase-4 (DPP...